MARKET

XAIR

XAIR

Beyond Air Inc
NASDAQ
0.7522
-0.0643
-7.88%
After Hours: 0.7749 +0.0227 +3.02% 18:29 12/26 EST
OPEN
0.8126
PREV CLOSE
0.8165
HIGH
0.8299
LOW
0.7500
VOLUME
170.18K
TURNOVER
--
52 WEEK HIGH
11.20
52 WEEK LOW
0.7500
MARKET CAP
6.02M
P/E (TTM)
-0.0998
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XAIR last week (1215-1219)?
Weekly Report · 5d ago
Beyond Air Inc. Announces Date for Upcoming Annual Stockholders Meeting
Reuters · 12/19 21:17
Beyond Air Signs Distribution Deals For LungFit PH
Benzinga · 12/17 12:36
Beyond Air signs new international LungFit PH distribution agreements
TipRanks · 12/17 12:35
Beyond Air Signs New LungFit PH Distribution Agreements in Germany and Brazil
Reuters · 12/17 12:31
Weekly Report: what happened at XAIR last week (1208-1212)?
Weekly Report · 12/15 10:21
Beyond Air Appoints New Financial Officer
TipRanks · 12/11 22:50
BEYOND AIR - ON DEC 8, CO APPOINTS DENTON DEWRELL AS PRINCIPAL FINANCIAL OFFICER - SEC FILING
Reuters · 12/11 22:29
More
About XAIR
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.

Webull offers Beyond Air Inc stock information, including NASDAQ: XAIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XAIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XAIR stock methods without spending real money on the virtual paper trading platform.